EyeCool TherapeuticsSeptember 2, 2025EyeCool Therapeutics Appoints Dr. Vance Thompson to Board of Directors
EyeCool TherapeuticsAugust 7, 2025EyeCool Therapeutics Announces Promising Results from Double-Masked Randomized Controlled Trial in Chronic Ocular Surface Pain (COSP)
EyeCool TherapeuticsMay 7, 2025EyeCool Therapeutics Announces Promising Results from Double-Masked Randomized Controlled Trial in Chronic Ocular Surface Pain (COSP)
